Wells Fargo’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Sell
30,086
-32,511
-52% -$200K ﹤0.01% 4835
2025
Q4
$483K Buy
62,597
+28,134
+82% +$251K ﹤0.01% 4524
2025
Q3
$304K Buy
34,463
+6,437
+23% +$47.9K ﹤0.01% 4671
2025
Q2
$116K Buy
28,026
+7,447
+36% +$46.7K ﹤0.01% 5106
2025
Q1
$124K Buy
20,579
+8
+0% +$49 ﹤0.01% 4987
2024
Q4
$106K Buy
20,571
+6,012
+41% +$23.7K ﹤0.01% 5175
2024
Q3
$43.5K Buy
14,559
+2,980
+26% +$8.09K ﹤0.01% 5393
2024
Q2
$34.5K Buy
11,579
+4,575
+65% +$37.7K ﹤0.01% 5424
2024
Q1
$82.6K Buy
7,004
+1,569
+29% +$18.1K ﹤0.01% 5003
2023
Q4
$44.2K Buy
5,435
+710
+15% +$5.1K ﹤0.01% 5321
2023
Q3
$38.4K Buy
4,725
+1,921
+69% +$18.4K ﹤0.01% 5321
2023
Q2
$20.9K Buy
2,804
+1,043
+59% +$7.24K ﹤0.01% 5723
2023
Q1
$8.77K Buy
1,761
+663
+60% +$4.2K ﹤0.01% 5903
2022
Q4
$5.3K Sell
1,098
-6,110
-85% -$30K ﹤0.01% 5755
2022
Q3
$73K Buy
7,208
+1,077
+18% +$15K ﹤0.01% 4771
2022
Q2
$85K Sell
6,131
-33,827
-85% -$539K ﹤0.01% 4735
2022
Q1
$677K Sell
39,958
-2,625
-6% -$45.2K ﹤0.01% 4188
2021
Q4
$1.05M Buy
42,583
+11,611
+37% +$366K ﹤0.01% 4064
2021
Q3
$1.14M Buy
30,972
+25,881
+508% +$951K ﹤0.01% 4133
2021
Q2
$249K Sell
5,091
-11,101
-69% -$463K ﹤0.01% 4937
2021
Q1
$481K Sell
16,192
-8,596
-35% -$241K ﹤0.01% 4709
2020
Q4
$634K Sell
24,788
-4,178
-14% -$83.9K ﹤0.01% 4356
2020
Q3
$420K Buy
28,966
+2,128
+8% +$35.2K ﹤0.01% 4480
2020
Q2
$554K Buy
26,838
+26,150
+3,801% +$692K ﹤0.01% 4253
2020
Q1
$22K Sell
688
-1,880
-73% -$47.1K ﹤0.01% 5577
2019
Q4
$41K Sell
2,568
-9,629
-79% -$138K ﹤0.01% 5578
2019
Q3
$177K Buy
12,197
+414
+4% +$6.72K ﹤0.01% 5036
2019
Q2
$213K Buy
11,783
+3,992
+51% +$90.4K ﹤0.01% 4942
2019
Q1
$277K Sell
7,791
-169
-2% -$6.68K ﹤0.01% 4661
2018
Q4
$321K Sell
7,960
-3,637
-31% -$222K ﹤0.01% 4625
2018
Q3
$1.01M Buy
11,597
+847
+8% +$84.2K ﹤0.01% 3966
2018
Q2
$887K Buy
10,750
+6,343
+144% +$388K ﹤0.01% 4077
2018
Q1
$158K Buy
4,407
+575
+15% +$22.3K ﹤0.01% 5100
2017
Q4
$141K Buy
3,832
+2,169
+130% +$97.9K ﹤0.01% 5155
2017
Q3
$94K Sell
1,663
-83
-5% -$3.92K ﹤0.01% 5259
2017
Q2
$46K Sell
1,746
-29
-2% -$738 ﹤0.01% 5411
2017
Q1
$44K Buy
1,775
+42
+2% +$667 ﹤0.01% 5485
2016
Q4
$23K Sell
1,733
-255
-13% -$3.79K ﹤0.01% 5594
2016
Q3
$32K Hold
1,988
﹤0.01% 5469
2016
Q2
$31K Sell
1,988
-873
-31% -$15.4K ﹤0.01% 5364
2016
Q1
$54K Buy
2,861
+255
+10% +$4.09K ﹤0.01% 5196
2015
Q4
$58K Sell
2,606
-1,057
-29% -$25K ﹤0.01% 5228
2015
Q3
$79K Sell
3,663
-1,611
-31% -$127K ﹤0.01% 5054
2015
Q2
$477K Sell
5,274
-11,435
-68% -$1.21M ﹤0.01% 4123
2015
Q1
$2.04M Buy
16,709
+15,172
+987% +$1.59M ﹤0.01% 3028
2014
Q4
$169K Buy
1,537
+1,457
+1,821% +$158K ﹤0.01% 4507
2014
Q3
$8K Sell
80
-253
-76% -$26.5K ﹤0.01% 5681
2014
Q2
$36K Buy
+333
New +$36.2K ﹤0.01% 5098

Other funds holding VSTM

Wells Fargo's VSTM Position: Q1 2026 in Review

Wells Fargo reduced its Verastem (VSTM) stake by 52% in Q1 2026, selling an estimated $200K and leaving 30,086 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #4835.

Wells Fargo first reported a position in VSTM in Q2 2014 and has held it in 48 quarters since. The position peaked at $2.04M in Q1 2015. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Wells Fargo held 30,086 shares of Verastem worth $159K as of Q1 2026.
  • Wells Fargo sold 32,511 Verastem shares in Q1 2026, an estimated $200K.
  • Verastem made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4835 holding.
  • Wells Fargo first reported a position in Verastem in Q2 2014 and has held it in 48 quarters since.
  • Wells Fargo's Verastem position peaked at $2.04M in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.